Literature DB >> 17060980

Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

David H Walker1, Nahed Ismail, Juan P Olano, Jere W McBride, Xue-Jie Yu, Hui-Min Feng.   

Abstract

Ehrlichia chaffeensis are small, obligately intracellular, endosomal bacteria with tropism for macrophages. Persistent infection in reservoir white-tailed deer is transmitted by lone star ticks. Flu-like illness can progress to severe multisystem disease with toxic shock-like syndrome, meningitis, or ARDS. The case-fatality rate is 2.7%. Leukopenia and thrombocytopenia are diagnostically useful. Granulomas are associated with control of the infection. Ehrlichial proteins and glycoproteins have been sequenced and expressed for diagnostic serology and vaccine development. Mouse models (mild disease and persistent infection with E. muris and fatal monocytotropic ehrlichiosis with a Japanese tick isolate) revealed that CD4 and CD8 T type 1 lymphocyte responses, IFN-gamma, TNF-alpha, and antibodies play roles in protective immunity, while a weak CD4 T-helper response, overproduction of TNF-alpha, and very high IL-10 are associated with toxic shock-like mortality. Protection against fatal ehrlichiosis was achieved by prior infection with low virulence E. muris. Acute clinical diagnosis is difficult except by PCR. Response to doxycycline is dramatic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 17060980      PMCID: PMC2263766     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  28 in total

1.  Outer membrane protein-specific monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis.

Authors:  J S Li; E Yager; M Reilly; C Freeman; G R Reddy; A A Reilly; F K Chu; G M Winslow
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

2.  Ehrlichial proliferation and acute hepatocellular necrosis in immunocompetent mice experimentally infected with the HF strain of Ehrlichia, closely related to Ehrlichia chaffeensis.

Authors:  H Okada; T Tajima; M Kawahara; Y Rikihisa
Journal:  J Comp Pathol       Date:  2001 Feb-Apr       Impact factor: 1.311

3.  Human ehrlichiosis: a rickettsial disease associated with severe cholestasis and multisystemic disease.

Authors:  M Moskovitz; R Fadden; T Min
Journal:  J Clin Gastroenterol       Date:  1991-02       Impact factor: 3.062

4.  Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family.

Authors:  S Wesley Long; Xiao-Feng Zhang; Hai Qi; Steven Standaert; David H Walker; Xue-Jie Yu
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis.

Authors:  J S Dumler; J E Dawson; D H Walker
Journal:  Hum Pathol       Date:  1993-04       Impact factor: 3.466

6.  Novel Immunoreactive glycoprotein orthologs of Ehrlichia spp.

Authors:  Jere W McBride; Jason E Comer; David H Walker
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

7.  Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization.

Authors:  Julia Shu-Yi Li; Frederick Chu; Andrew Reilly; Gary M Winslow
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival.

Authors:  Mingqun Lin; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting.

Authors:  Juan P Olano; Wayne Hogrefe; Brent Seaton; David H Walker
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Hepatic pathology in human monocytic ehrlichiosis. Ehrlichia chaffeensis infection.

Authors:  Ann E Sehdev; J Stephen Dumler
Journal:  Am J Clin Pathol       Date:  2003-06       Impact factor: 2.493

View more
  20 in total

1.  Early induction of interleukin-10 limits antigen-specific CD4⁺ T cell expansion, function, and secondary recall responses during persistent phagosomal infection.

Authors:  Abinav Kumar Singh; Nagaraja R Thirumalapura
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

Review 2.  CD11c+ T-bet+ memory B cells: Immune maintenance during chronic infection and inflammation?

Authors:  Gary M Winslow; Amber M Papillion; Kevin J Kenderes; Russell C Levack
Journal:  Cell Immunol       Date:  2017-07-19       Impact factor: 4.868

3.  Review: Protective Immunity and Immunopathology of Ehrlichiosis.

Authors:  Nahed Ismail; Aditya Sharma; Lynn Soong; David H Walker
Journal:  Zoonoses (Burlingt)       Date:  2022-07-05

4.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

5.  Antigenic protein modifications in Ehrlichia.

Authors:  S Thomas; N Thirumalapura; E C Crossley; N Ismail; D H Walker
Journal:  Parasite Immunol       Date:  2009-06       Impact factor: 2.280

6.  Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis.

Authors:  Yubin Zhang; Vinh Thai; Amanda McCabe; Maura Jones; Katherine C MacNamara
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

7.  Recombinant Ehrlichia P29 protein induces a protective immune response in a mouse model of ehrlichiosis.

Authors:  Nagaraja R Thirumalapura; Patricia A Crocquet-Valdes; Tais B Saito; Sunil Thomas; Jere W McBride; David H Walker
Journal:  Vaccine       Date:  2013-10-19       Impact factor: 3.641

8.  Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis.

Authors:  Nagaraja R Thirumalapura; Emily C Crossley; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

9.  Detection of A. phagocytophilum and E. chaffeensis in patient and mouse blood and ticks by a duplex real-time PCR assay.

Authors:  Tuo Dong; Zhangyi Qu; Lijuan Zhang
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  Structure-based vaccines provide protection in a mouse model of ehrlichiosis.

Authors:  Sunil Thomas; Nagaraja R Thirumalapura; Patricia A Crocquet-Valdes; Bruce A Luxon; David H Walker
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.